Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
The Healthcare ETF Showdown: Broad Global Health or Targeted Pharma Power?
Deciding between Invesco Pharmaceuticals ETF (PJP +0.25%) and iShares Global Healthcare ETF (IXJ +0.06%) involves choosing between a focused bet on U.S. drugmakers and broad exposure to global healthcare sectors. While both Invesco Pharmaceuticals…
Bristol Myers Squibb vs. Vertex: Which Pharma Stock Is a Better Buy for 2027?
Investors choosing between Bristol Myers Squibb (BMY -1.57%) and Vertex Pharmaceuticals (VRTX +0.85%) must decide between a steady value play and a high-growth innovator as they look toward 2027. Bristol Myers Squibb operates as a diversified drug…
Diwali Muhurat Trading 2026: 3 Stocks With 25% Potential Upside
Samvat 2083: Muhurat trading should be approached with a quality-first investment strategy. Summary is AI-generated, newsroom-reviewed Aurobindo Pharma, Balkrishna Industries, and Mahindra & Mahindra are top Diwali Muhurat trading picks Mahindra &…
Ascendis Pharma A/S (NASDAQ:ASND) Upgraded at Wall Street Zen
Ascendis Pharma A/S (NASDAQ:ASND - Get Free Report) was upgraded by equities researchers at Wall Street Zen from a 'hold' rating to a 'buy' rating in a note issued to investors on Sunday, Wall Street Zen reports. Can BioMarin Stock Live Up to Wall…
BridgeBio Pharma, Inc. $BBIO Stake Increased by Candriam S.C.A.
Candriam S.C.A. increased its stake in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 133.9% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The…
French director Marine Atlan receives Reflet d'Or at GIFF
WHO candidate Maria Neira: ‘We need to rebuild credibility and trust' Read more: WHO candidate Maria Neira: ‘We need to rebuild credibility and trust' China blocks SoftBank's $5.4bn takeover of ABB's robotics division Read more: China…
Rakuten Investment Management Inc. Purchases 26,660 Shares of Royalty Pharma PLC $RPRX
Rakuten Investment Management Inc. acquired a new stake in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional…
Indian Stock Market: Sensex, Nifty Start Samvat 2083 Bullish in Muhurat Trading
Indian benchmark indices Sensex and Nifty commenced the special Muhurat trading session for Samvat 2083 on a strong bullish note, reflecting investor optimism for the new Hindu calendar year. Benchmark indices Sensex and Nifty started the special…
7,274 Shares of Ascendis Pharma A/S $ASND Bought by Mirae Asset Global Investments Co. Ltd.
Mirae Asset Global Investments Co. Ltd. bought a new position in shares of Ascendis Pharma A/S (NASDAQ:ASND - Free Report) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund…
Mirae Asset Global Investments Co. Ltd. Buys 20,183 Shares of BridgeBio Pharma, Inc. $BBIO
Mirae Asset Global Investments Co. Ltd. bought a new stake in BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission…
Indian Stock Markets See Marginal Dip in Special Muhurat Trading Session
Indian stock markets concluded their special Diwali Muhurat trading session with a marginal dip, as benchmark indices Sensex and Nifty ended lower, breaking a robust seven-day rally amidst investor profit-taking. Benchmark indices Sensex and Nifty…
Stock markets begin Samvat 2083 on a firm note in special Muhurat trading
Benchmark indices Sensex and Nifty started the special Muhurat trading session on a bullish note on Sunday (November 8, 2026), supported by buying in blue-chips such as Sun Pharma, Tata Steel and ICICI Bank. Continuing the prevailing bullish trend…
Sensex, Nifty end lower in Diwali muhurat trading
Benchmark indices Sensex and Nifty ended marginally lower in the special Diwali Muhurat trading session on Sunday amid profit-taking by investors after a seven-day rally. After starting the special trading session to mark the beginning of Hindu…
Ginkgo Bioworks: 3 Key Takeaways for Long-Term Investors
On its third-quarter 2026 earnings call, held on Nov. 5, 2026, Ginkgo Bioworks (DNA +13.35%) announced a strategic transition toward commercializing autonomous laboratory hardware and cloud data services. For long-term investors, this operational…
Wall Street Is Ignoring Bristol Myers Squibb's Cash Machine -- and That's an Opportunity for Income Investors
Bristol Myers Squibb (BMY -1.57%) traces its history back to the mid-1800s. It is a proven survivor in the highly competitive and innovation-driven pharmaceutical sector. That can't save the company from the normal dynamics of the drug industry, as…
Receive a Daily briefing on Pharma Industry News
Get Started